Objective To explore the factors influencing the complete response (CR) rate of liver cancer after percutaneous radiofrequency ablation (PRFA). Methods A total of 60 patients with liver cancer treated with ultrasound-guided PRFA were recruited from our hospital. According to the postoperative results of contrast-enhanced ultrasound, the patients were divided into CR group and in-complete response (ICR) group. The ablation number of lesions and CR rate under the influence of different factors were recorded and the differences of each factor between the two groups were compared. Further multiple logistic regression was used to analyze the independent influencing factors of tumor CR rate after PRFA. Results A total of 94 lesions were completely ablated after PRFA treatment, and the total CR rate was 91.26%. Tumor type, special anatomical position, maximum tumor diameter, ablative margin, ablation energy, and central temperature were significantly correlated with the CR rate of tumor (P<0.05). Further multiple logistic regression results showed that tumor type (P=0.024), special anatomical position (P=0.031), maximum tumor diameter (P=0.001), ablative margin (P<0.001), ablation energy (P=0.003) and central temperature of tumor (P=0.009) were independent influencing factors of tumor CR rate after PRFA. Conclusion Tumor type, special anatomic location, maximum tumor diameter,ablative margin, ablation energy, and central temperature of tumor have important effects on CR rate of liver cancer after PRFA.
LIU Congcong
,
SHI Baomin
. Factors influencing complete response rate of liver cancer after percutaneous radiofrequency ablation[J]. Surgical Research and New Technique, 2020
, 9(1)
: 1
-5
.
DOI: 10.3969/j.issn.2095-378X.2020.01.001
[1] Torre L A, Bray F, Siegel R L, et al.Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108.
[2] Chen W, Zheng R, Baade P D, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132.
[3] 中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志,2017,16(7):635-647.
[4] 周勇旭, 陆朝阳, 潘博, 等. 射频消融术治疗肝癌的研究新进展[J]. 现代生物医学进展, 2015, 15(05):991-994.
[5] Dupré A, Gagnière J, Chen Y, et al.Management of synchronous colorectal liver metastases[J]. Bull Cancer, 2013, 100(4):363-371.
[6] 练远书, 杨浩. 经皮射频消融与手术切除治疗小肝癌的临床效果对比[J]. 临床医学研究与实践, 2016, 1(06):16+18.
[7] Lin Y H, Chiou Y Y, Chou Y H, et al.Radiofrequency ablation for recurrent hepatocellular carcinoma in postresectional patients: prognostic factors analysis[J]. Eur J Gastroenterol Hepatol, 2011,23(12):1239-1244.
[8] 任炜,杨薇.射频消融治疗复发性肝癌疗效及预后因素分析[J]. 介入放射学杂志, 2015,24(10):923-927.
[9] 霍峰. 超声引导射频消融治疗肝脏恶性肿瘤286例肿瘤残留危险因素研究[J]. 黑龙江科学, 2015,6(12):22-23.
[10] Fonseca A Z, Santin S, Gomes L G, et al.Complications of radiofrequency ablation of hepatic tumors: frequency and risk factors[J]. World J Hepatol, 2014,6(3):107-113.
[11] 段浩朋, 赵永福. 经皮肝穿刺射频消融治疗临近肝脏大血管肝癌的安全性及疗效分析[J].河南医学研究, 2016,25(4):638-640.
[12] 徐建波, 祁付珍, 许刚,等. 原发性中小肝癌手术与射频消融治疗的疗效分析[J]. 现代肿瘤医学, 2013,21(8):1822-1825.
[13] 李蕊利, 万娟. 原发性肝癌射频消融预后的影响因素分析[J]. 现代肿瘤医学, 2015,23(20):2970-2972.
[14] 魏涛. 超声引导经皮射频消融治疗肝癌的疗效及影响疗效的因素研究[J]. 齐齐哈尔医学院学报, 2016, 37(5):605-606.
[15] Ke S, Ding X M, Qian X J, et al.Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified?[J]. World J Gastroenterol, 2013,19(42):7389-7398.
